共 258 条
[1]
Hurria A(2012)Senior adult oncology J Natl Compr Canc Netw 10 162-209
[2]
Browner IS(1997)Polypharmacy in the older patient with cancer Cancer Control 4 419-428
[3]
Cohen HJ(2005)Developing a cancer-specific geriatric assessment: a feasibility study Cancer 104 1998-2005
[4]
Denlinger CS(2005)Predicting and preventing adverse drug reactions in the very old Drugs Aging 22 375-392
[5]
deShazo M(2000)Management of cancer in the older person: a practical approach Oncologist 5 224-237
[6]
Extermann M(2005)Use of comprehensive geriatric assessment in older cancer patients: recommendations from the Task Force on CGA of the International Society of Geriatric Oncology (SIOG) Crit Rev Oncol Hematol 55 241-252
[7]
Ganti AK(2012)Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes J Clin Epidemiol 65 989-995
[8]
Holland JC(2004)Aging biology and geriatric clinical pharmacology Pharmacol Rev 56 163-184
[9]
Holmes HM(2002)Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey JAMA 287 337-344
[10]
Karlekar MB(2012)Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer J Geriatr Oncol 3 228-237